-
Signature
-
/s/ Charles Schoch, as Attorney-In-Fact for Paul Peter Tak
-
Issuer symbol
-
CADL
-
Transactions as of
-
25 Jun 2025
-
Net transactions value
-
+$199,997
-
Form type
-
4
-
Filing time
-
26 Jun 2025, 08:30:12 UTC
Quoteable Key Fact
"Paul Peter Tak filed Form 4 for Candel Therapeutics, Inc. (CADL) on 26 Jun 2025."
Quick Takeaways
- This page summarizes Paul Peter Tak's Form 4 filing for Candel Therapeutics, Inc. (CADL).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 26 Jun 2025, 08:30.
What Changed
- Previous filing in this sequence was filed on 20 Mar 2025.
- Current net transaction value: +$199,997.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Tak Paul Peter |
Chief Executive Officer, Director |
C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM |
/s/ Charles Schoch, as Attorney-In-Fact for Paul Peter Tak |
26 Jun 2025 |
0001873905 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CADL |
Common Stock |
Award |
$199,997 |
+42,826 |
+19% |
$4.67 |
268,566 |
25 Jun 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: